Evolent Health, Inc. EVH 深 滬
等待開盤 09-11 09:30:00 美东时间
9.19
-0.800
-8.01%
華盛通- 最 高10.0599
- 今 開9.90
- 成交量 206.44万股
- 最 低 9.19
- 昨 收 9.99
- 總市值 10.84亿
- 52周最高 31.32
- 市盈率 靜 --
- 換手率 1.75%
- 52周最低 7.06
- 委 比 94.87%
- 總股本 1.18亿
- 歷史最高 39.779
- 量 比 1.06
- 振 幅 8.71%
- 歷史最低 3.50
- 每 手 1
- 風險率 6.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
The Analyst Verdict: Evolent Health In The Eyes Of 4 Experts
During the last three months, 4 analysts shared their evaluations of Evolent He...
09-09 20:01
BTIG Reiterates Buy on Evolent Health, Maintains $20 Price Target
BTIG analyst David Larsen reiterates Evolent Health (NYSE:EVH) with a Buy and maintains $20 price target.
09-09 19:28
Freshpet edges higher amid long call at Hedgeye
Freshpet (NASDAQ:FRPT) ticked higher by 1.2% amid a new long call at Hedgeye, which sees the potential for the shares to triple. "Its shares have fallen by nearly two-thirds this year as investors di...
09-09 02:12
Piper Sandler Maintains Overweight on Evolent Health, Raises Price Target to $18
Piper Sandler analyst Jessica Tassan maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $16 to $18.
08-28 22:21
Evolent Health Closes $166.75M Convertible Notes Sale
Evolent Health ( ($EVH) ) just unveiled an update. On August 18, 2025, Evolent ...
08-22 05:28
Evolent Health prices convertible notes offering
Evolent Health (NYSE:EVH) priced $145M of 4.50% convertible senior notes due 2031, offered to qualified institutional buyers under Rule 144A. The deal size was raised from $140M, with an option for in...
08-19 19:32
中集·陕汽“好牵挂”新能源头挂列车批量交付，创跨境运输新能源头挂列车交付纪录
8月18日，由中集灯塔、陕汽重卡和崇左城建集团联合筹办的崇左港公水联运服务首航仪式暨中集・陕汽新能源头挂列车交付仪式在广西壮族自治区崇左港隆重举行。 崇左市交通...
08-19 10:22
Evolent shares are trading lower after the company reported worse-than-expected Q2 sales results, issued Q3 sales guidance below estimates, and cut its FY25 sales guidance below estimates.
Evolent shares are trading lower after the company reported worse-than-expected...
08-08 05:05
Evolent Health Lowers FY2025 Sales Guidance from $2.060B-$2.110B to $1.850B-$1.880B vs $2.055B Est
Evolent Health (NYSE:EVH) lowers FY2025 sales outlook from $2.060 billion-$2.110 billion to $1.850 billion-$1.880 billion vs $2.055 billion estimate.
08-08 04:39
